Mode
Text Size
Log in / Sign up

Narrative review proposes AI framework for precision oncology task-architecture alignment

Narrative review proposes AI framework for precision oncology task-architecture alignment
Photo by Jonathan Kemper / Unsplash
Key Takeaway
Note that single-model AI approaches have clear limitations in clinical reasoning and workflow integration.

This narrative review examines the application of large language models, multimodal extensions, AI agents, and multi-agent systems within the context of precision oncology. The publication does not report a specific population, sample size, or setting for these technologies. Instead, the authors focus on synthesizing an analytical framework centered on task-architecture alignment for the design, evaluation, and clinical translation of AI systems in this field.

The review highlights significant challenges associated with current AI implementations. Specifically, the authors identify that single-model approaches have clear limitations in constructing complex clinical reasoning pathways. These limitations extend to ensuring the traceability and verifiability of decision processes and integrating deeply with established clinical workflows. The text does not report primary or secondary outcomes, adverse events, or specific safety data regarding these AI tools.

The authors conclude by emphasizing the need for structured frameworks to guide the clinical translation of these technologies. The review suggests that without such alignment, the integration of AI agents into oncology practice may face substantial hurdles regarding workflow integration and decision transparency. The practice relevance is framed around the necessity of these analytical frameworks rather than specific efficacy data.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
With the rapid growth of electronic health records, medical imaging, and high-throughput omics data, precision oncology faces increasing demands for cross-modal information integration and complex clinical decision support. In recent years, large language models (LLMs) and their multimodal extensions have opened new technological avenues for addressing these challenges and have shown considerable promise across a range of applications. This review provides a structured narrative overview of the current applications of these technologies across the precision oncology care continuum, encompassing key stages such as cancer screening, diagnosis, staging, treatment recommendation, and clinical documentation. However, single-model approaches still have clear limitations in constructing complex clinical reasoning pathways, ensuring the traceability and verifiability of decision processes, and integrating deeply with established clinical workflows. Against this backdrop, AI agents with autonomous planning and coordination capabilities, together with multi-agent systems (MAS), have emerged as an important new direction in precision oncology research. Building on this development, we further propose an analytical framework centered on task–architecture alignment, emphasizing that foundation models, single-agent systems, and multi-agent systems should be selected according to the complexity and risk profile of the clinical task. Such a framework may provide a useful basis for the design, evaluation, and clinical translation of AI systems in precision oncology.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.